CD8A and neoplasm: Furthermore, in the presence of M0 and TAM-like MDMs, SKOV3-R2+ cells opsonized with 3C23K-CHO tended to increase the proportion of CD8+ CD183+ T cells, and the opsonization of tumor cells with murlentamab significantly increased activated CD8+ T cell proportion (Figure 4C).